Company Information
Aros Pharma is a biotech company focusing on novel pharmaceuticals targeting unmet needs within pain relief, infectious disease, inflammation, respiratory diseases and immuno-suppressed patients.
Projects of interest are in late pre-clinical, phase I or early phase II.
Contact
CEO Henrik Blou
cell: (+45) 28 61 68 45
email: hb@arospharma.com
Financials
Aros Pharma is financed by Novo A/S - the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation. Novo A/S’ objective is to manage the Foundation’s financial assets through investments in the life science area and in a broad portfolio of financial assets.